Bp Plc Raised Jpmorgan Chase Co (JPM) Stake; Neuberger Berman Group Has Lowered Novartis Ag (NVS) Stake By $1.39 Million

Novartis AG (NYSE:NVS) Logo

Neuberger Berman Group Llc decreased Novartis Ag (NVS) stake by 4.98% reported in 2018Q3 SEC filing. Neuberger Berman Group Llc sold 16,115 shares as Novartis Ag (NVS)’s stock rose 5.30%. The Neuberger Berman Group Llc holds 307,438 shares with $26.49 million value, down from 323,553 last quarter. Novartis Ag now has $207.15B valuation. The stock decreased 0.02% or $0.02 during the last trading session, reaching $88.83. About 2.42 million shares traded. Novartis AG (NYSE:NVS) has risen 4.85% since February 14, 2018 and is uptrending. It has outperformed by 4.85% the S&P500. Some Historical NVS News: 11/05/2018 – U.S. FDA SAYS APPROVED GILENYA (FINGOLIMOD) TO TREAT RELAPSING MULTIPLE SCLEROSIS IN CHILDREN & ADOLESCENTS AGE 10 YRS & OLDER; 19/04/2018 – NOVARTIS AG NOVN.S CEO SAYS SANDOZ HAD A TOUGH FIRST QUARTER, STRONG PERFORMANCE OUTSIDE US BUT CONTINUED PRICE PRESSURES THERE, LOOKING FORWARD TO UPCOMING BIOSIMILARS LAUNCHES; 02/05/2018 – STAT Plus: Pharmalittle: Novartis wins added use for its CAR-T drug; former Valeant exec faces a fraud trial; 19/03/2018 – #3 With Novartis and Roche gunning to carve up Eylea franchise, Regeneron has another PhIII success story to tell $NVS $RHHBY $REGN; 10/05/2018 – NOVARTIS INDIA 4Q NET INCOME 264.7M RUPEES; 11/04/2018 – MYLAN AND BIOCON SEEK TO ACCELERATE INTRODUCTION OF ADALIMUMAB; 16/05/2018 – Top Novartis lawyer quits after payments to Trump aide; 09/04/2018 – Novartis to Pay $218 a Share in Cash for AveXis; 09/04/2018 – Novartis to Buy AveXis for $8.7 Billion; 09/05/2018 – ? Novartis in payment to […]

Bp Plc increased Jpmorgan Chase Co (JPM) stake by 8.49% reported in 2018Q3 SEC filing. Bp Plc acquired 36,000 shares as Jpmorgan Chase Co (JPM)’s stock declined 10.86%. The Bp Plc holds 460,000 shares with $51.90M value, up from 424,000 last quarter. Jpmorgan Chase Co now has $342.77 billion valuation. The stock increased 0.48% or $0.49 during the last trading session, reaching $103.09. About 10.75 million shares traded. JPMorgan Chase & Co. (NYSE:JPM) has declined 3.12% since February 14, 2018 and is downtrending. It has underperformed by 3.12% the S&P500. Some Historical JPM News: 04/05/2018 – JPMorgan Presenting at Deutsche Bank Conference May 29; 07/03/2018 – AUTODESK INC ADSK.O : JP MORGAN RAISES TARGET PRICE TO $150 FROM $130; 30/04/2018 – JPMorgan Intrepid European Adds Erste, Exits Vivendi; 07/05/2018 – Integrated Device Presenting at JPMorgan Conference May 15; 02/04/2018 – JPMorgan’s top blockchain executive Amber Baldet to leave for own startup; 09/04/2018 – Rate swaps show concerns about Fed policy mistake -JPMorgan; 16/05/2018 – Techmeme: Sources: the health care joint venture announced by Berkshire Hathaway, Amazon, and JPMorgan Chase in January is; 13/04/2018 – JPMorgan Chase 1Q Net $8.71B; 06/03/2018 – Union Pacific Corporation CFO Rob Knight to Address the J.P. Morgan 2018 Aviation, Transportation and Industrials Conference; 27/03/2018 – WYNN RESORTS LTD WYNN.O : JP MORGAN RAISES TARGET PRICE TO $214 FROM $196

Among 5 analysts covering Novartis (NYSE:NVS), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Novartis had 5 analyst reports since September 10, 2018 according to SRatingsIntel. The company was upgraded on Monday, November 26 by Cowen & Co. The firm has “Buy” rating given on Monday, September 10 by Bank of America. The rating was upgraded by Citigroup on Tuesday, September 11 to “Buy”. The company was upgraded on Monday, November 19 by Goldman Sachs. As per Tuesday, December 11, the company rating was reinitiated by Jefferies.

More notable recent Novartis AG (NYSE:NVS) news were published by: Seekingalpha.com which released: “Novartis Q4 2018 Earnings Preview – Seeking Alpha” on January 29, 2019, also Streetinsider.com with their article: “Novartis (NVS) receives FDA approval for Egaten for the treatment of fascioliasis – StreetInsider.com” published on February 13, 2019, Seekingalpha.com published: “Sandoz launches Symjepi in U.S. – Seeking Alpha” on January 16, 2019. More interesting news about Novartis AG (NYSE:NVS) were released by: Seekingalpha.com and their article: “Novartis backs away from Surface Oncology’s SRF388 – Seeking Alpha” published on February 04, 2019 as well as Seekingalpha.com‘s news article titled: “Novartis proposes dividend raise to CHF 2.85 – Seeking Alpha” with publication date: January 30, 2019.

Neuberger Berman Group Llc increased Voya Financial Inc (NYSE:VOYA) stake by 20,928 shares to 115,509 valued at $5.74 million in 2018Q3. It also upped Spdr Ser Tr S&P Dividend Etf (SDY) stake by 6,974 shares and now owns 20,467 shares. Western Digital Corp (NASDAQ:WDC) was raised too.

Bp Plc decreased Pepsico Inc (NYSE:PEP) stake by 3,000 shares to 177,000 valued at $19.79M in 2018Q3. It also reduced Broadcom Inc stake by 26,000 shares and now owns 24,000 shares. Coca Cola Co/The (NYSE:KO) was reduced too.

More notable recent JPMorgan Chase & Co. (NYSE:JPM) news were published by: Benzinga.com which released: “J P Morgan Chase & Co (NYSE:JPM) – J.P. Morgan Executive Director To Lead Trucking Freight Futures For FreightWaves – Benzinga” on February 12, 2019, also Seekingalpha.com with their article: “JPMorgan pushes ahead in ETFs – Seeking Alpha” published on January 28, 2019, Benzinga.com published: “JPMorgan Q4 Earnings Print Misses Expectations (NYSE:JPM) – Benzinga” on January 15, 2019. More interesting news about JPMorgan Chase & Co. (NYSE:JPM) were released by: Seekingalpha.com and their article: “JPMorgan: Not A Buying Opportunity – Seeking Alpha” published on January 28, 2019 as well as Bizjournals.com‘s news article titled: “Which banks should worry the most with JP Morgan’s presence in the Triangle? – Triangle Business Journal” with publication date: January 18, 2019.

Among 6 analysts covering JPMorgan Chase (NYSE:JPM), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. JPMorgan Chase had 6 analyst reports since September 17, 2018 according to SRatingsIntel. The stock has “Market Perform” rating by BMO Capital Markets on Wednesday, January 16. Citigroup maintained JPMorgan Chase & Co. (NYSE:JPM) rating on Wednesday, September 26. Citigroup has “Neutral” rating and $125 target. The company was downgraded on Tuesday, January 8 by Jefferies. Credit Suisse maintained it with “Outperform” rating and $128 target in Friday, December 7 report. The rating was maintained by Morgan Stanley with “Overweight” on Tuesday, January 8. The firm has “Buy” rating given on Monday, September 17 by Bank of America.

Since October 19, 2018, it had 2 buys, and 5 insider sales for $4.86 million activity. CROWN JAMES S also bought $518,950 worth of JPMorgan Chase & Co. (NYSE:JPM) on Tuesday, February 5. BACON ASHLEY sold 5,831 shares worth $599,304. Beer Lori A also sold $1.40 million worth of JPMorgan Chase & Co. (NYSE:JPM) shares. Shares for $125,281 were bought by HOBSON MELLODY L. Friedman Stacey sold 3,022 shares worth $317,310. Scher Peter also sold $1.96M worth of JPMorgan Chase & Co. (NYSE:JPM) shares. Petno Douglas B sold $1.22M worth of stock or 11,659 shares.

JPMorgan Chase & Co. (NYSE:JPM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.